Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Diseases, Disorders & Medical Cure Mucolipidosis

Cure Mucolipidosis

Fiscal year ending 2023. Filed on April 9, 2024.

402 Park Ave
Belleville, Illinois 62220

Cure Mucolipidosis (EIN: 86-3929222) has filed an IRS Form 990 since fiscal year 2022. In its fiscal year 2023 IRS Form 990 filing, Cure Mucolipidosis, a 501(c)(3) charitable organization, reported compensation for 9 employees. Among the employees shown here, the average compensation is $0.

Revenue, expenses, and employee compensation

Revenue

$52,799

Expenses

$43,352

Employee compensation

—
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Nadia Jack
Board Member
$0
Daniel Peach
Board Member
$0
Truls Roll
Board Member
$0
John Delaney
Board Member
$0
Jenny Noble
Secretary
$0
Jacqueline James
President
$0
Kevin Gates
Treasurer
$0
Charloette Gilbert
Board Member
$0
Susan Kester
Board Member
$0

Benchmark Employee Compensation

Mission Statement

CURE MUCOLIPIDOSIS IS A GLOBAL ORGANIZATION THAT IS COMMITTED TO THE IDENTIFICATION AND TREATMENT OF MUCOLIPIDOSIS THROUGH EDUCATION, ADVOCACY AND RESEARCH.

Revisions to this organization profile

March 12, 2025:
2024 Cure Mucolipidosis 990 filed
April 9, 2024:
2023 Cure Mucolipidosis 990 filed
July 18, 2023:
2022 Cure Mucolipidosis 990 filed

Get an email when new compensation information is released for Cure Mucolipidosis

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →